In a report published Wednesday, Morgan Stanley analyst Andrew Schenker reiterated an Overweight rating and $55.00 price target on HCA Holdings HCA.
In the report, Morgan Stanley noted, “HCA issued initial FY14 guidance including reform benefit. While the high end of guidance came in above consensus, it is below our estimate of $6.94B. Upside in our model is primarily based on a higher reform benefit of 4% of adj. EBITDA vs. guidance of 1% to 2%.”
HCA Holdings closed on Tuesday at $48.52.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in